xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05964348</url>
    </required_header>
    <id_info>
      <org_study_id>CHUBX 2022/66</org_study_id>
      <nct_id>NCT05964348</nct_id>
    </id_info>
    <brief_title>REGISTRY for the Use of a Software for Automatic Detection of the Evolution of Aneurysmal Volume and Graft Migration After EVAR (EndoVascular Aneurysm Repair)</brief_title>
    <acronym>AI-EVAR-FOLLOW</acronym>
    <official_title>REGISTRY for the Use of a Software for Automatic Detection of the Evolution of Aneurysmal Volume and Graft Migration After EVAR (EndoVascular Aneurysm Repair)</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>University Hospital, Bordeaux</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
      <collaborator>
        <agency>Nurea</agency>
        <agency_class>Industry</agency_class>
      </collaborator>
    </sponsors>
    <source>University Hospital, Bordeaux</source>
    <oversight_info>
      <has_dmc>No</has_dmc>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        The objective of this registry is to find and validate a correlation between morphological&#xD;
        indicators such as volume sac evolution, graft migration or length between anatomical&#xD;
        landmarks with aneurysm rupture risk or complications such as endoleaks requiring&#xD;
        re-intervention… Secondary objectives are the validation of the reproducibility and accuracy&#xD;
        of a dedicated fully automated software enabling Abdominal Aortic Aneurysm (AAA) segmentation&#xD;
        to measure AAA diameter, volume evolution and growth over time, proximal and distal sealing&#xD;
        zones analyze as well as device migration and integrity after EVAR on computed tomography&#xD;
        angiography (CTA). This validation is in comparison with semi-automated analyse controlled by&#xD;
        physician.&#xD;
      </textblock>
    </brief_summary>
    <overall_status>Withdrawn</overall_status>
    <why_stopped>
      the study was no longer of scientific interest, and other publications rendered it obsolete&#xD;
    </why_stopped>
    <start_date type="Actual">April 5, 2023</start_date>
    <completion_date type="Anticipated">January 31, 2024</completion_date>
    <primary_completion_date type="Anticipated">August 31, 2023</primary_completion_date>
    <study_type>Observational</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <observational_model>Cohort</observational_model>
      <time_perspective>Retrospective</time_perspective>
    </study_design_info>
    <primary_outcome>
      <measure>Collection of the different events and complications of the aneurysm post EVAR</measure>
      <time_frame>Month 1</time_frame>
      <description>Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Collection of the different events and complications of the aneurysm post EVAR</measure>
      <time_frame>Month 3</time_frame>
      <description>Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Collection of the different events and complications of the aneurysm post EVAR</measure>
      <time_frame>Month 6</time_frame>
      <description>Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Collection of the different events and complications of the aneurysm post EVAR</measure>
      <time_frame>Month 12</time_frame>
      <description>Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of aneurysm sac volume evolution</measure>
      <time_frame>Month 1</time_frame>
      <description>Measurement of the aneurysm sac volume in cc on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of aneurysm sac volume evolution</measure>
      <time_frame>Month 3</time_frame>
      <description>Measurement of the aneurysm sac volume in cc on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of aneurysm sac volume evolution</measure>
      <time_frame>Month 6</time_frame>
      <description>Measurement of the aneurysm sac volume in cc on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of aneurysm sac volume evolution</measure>
      <time_frame>Month 12</time_frame>
      <description>Measurement of the aneurysm sac volume in cc on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of morphological neck characteristics</measure>
      <time_frame>Month 6 before intervention</time_frame>
      <description>Measurement of the morphological neck characteristics in mm on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of morphological neck characteristics</measure>
      <time_frame>Month 1</time_frame>
      <description>Measurement of the morphological neck characteristics in mm on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of morphological neck characteristics</measure>
      <time_frame>Month 3</time_frame>
      <description>Measurement of the morphological neck characteristics in mm on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of morphological neck characteristics</measure>
      <time_frame>Month 6</time_frame>
      <description>Measurement of the morphological neck characteristics in mm on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of morphological neck characteristics</measure>
      <time_frame>Month 12</time_frame>
      <description>Measurement of the morphological neck characteristics in mm on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of graft migration</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>Measurement of the graft migration if existing on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of graft migration</measure>
      <time_frame>Month 1</time_frame>
      <description>Measurement of the graft migration if existing on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of graft migration</measure>
      <time_frame>Month 3</time_frame>
      <description>Measurement of the graft migration if existing on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of graft migration</measure>
      <time_frame>Month 6</time_frame>
      <description>Measurement of the graft migration if existing on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of graft migration</measure>
      <time_frame>Month 12</time_frame>
      <description>Measurement of the graft migration if existing on the CT scans available</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of length between anatomical points evolution</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of length between anatomical points evolution</measure>
      <time_frame>Month 1</time_frame>
      <description>Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of length between anatomical points evolution</measure>
      <time_frame>Month 3</time_frame>
      <description>Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of length between anatomical points evolution</measure>
      <time_frame>Month 6</time_frame>
      <description>Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Measurement of length between anatomical points evolution</measure>
      <time_frame>Month 12</time_frame>
      <description>Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.</description>
    </primary_outcome>
    <secondary_outcome>
      <measure>Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation</measure>
      <time_frame>Month</time_frame>
      <description>Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation</measure>
      <time_frame>Month 1</time_frame>
      <description>Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation</measure>
      <time_frame>Month 3</time_frame>
      <description>Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation</measure>
      <time_frame>Month 6</time_frame>
      <description>Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation</measure>
      <time_frame>Month 12</time_frame>
      <description>Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between measures (intra observer variability)</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>Descriptive analysis of the different measurements by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between measures (intra observer variability)</measure>
      <time_frame>Month 1</time_frame>
      <description>Descriptive analysis of the different measurements by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between measures (intra observer variability)</measure>
      <time_frame>Month 3</time_frame>
      <description>Descriptive analysis of the different measurements by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between measures (intra observer variability)</measure>
      <time_frame>Month 6</time_frame>
      <description>Descriptive analysis of the different measurements by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Repeatability between measures (intra observer variability)</measure>
      <time_frame>Month 12</time_frame>
      <description>Descriptive analysis of the different measurements by overlaps metric analysis</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation (sec)</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>The time for segmentation by junior/senior surgeon and software is recorded</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation (sec)</measure>
      <time_frame>Month 1</time_frame>
      <description>The time for segmentation by junior/senior surgeon and software is recorded</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation (sec)</measure>
      <time_frame>Month 3</time_frame>
      <description>The time for segmentation by junior/senior surgeon and software is recorded</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation (sec)</measure>
      <time_frame>Month 6</time_frame>
      <description>The time for segmentation by junior/senior surgeon and software is recorded</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation (sec)</measure>
      <time_frame>Month 12</time_frame>
      <description>The time for segmentation by junior/senior surgeon and software is recorded</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation in comparison with semi-automated segmentation</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>Description of the average time between the different techniques.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation in comparison with semi-automated segmentation</measure>
      <time_frame>Month 1</time_frame>
      <description>Description of the average time between the different techniques.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation in comparison with semi-automated segmentation</measure>
      <time_frame>Month 3</time_frame>
      <description>Description of the average time between the different techniques.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation in comparison with semi-automated segmentation</measure>
      <time_frame>Month 6</time_frame>
      <description>Description of the average time between the different techniques.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Average time for segmentation in comparison with semi-automated segmentation</measure>
      <time_frame>Month 12</time_frame>
      <description>Description of the average time between the different techniques.</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Total Volume measurement of AAA</measure>
      <time_frame>6 months before intervention</time_frame>
      <description>Description of the volume measurement of the AAA with the following items:&#xD;
  Volume circulating&#xD;
  Intraluminal thrombus volume&#xD;
  Calcification volume</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Total Volume measurement of AAA</measure>
      <time_frame>Month 1</time_frame>
      <description>Description of the volume measurement of the AAA with the following items:&#xD;
  Volume circulating&#xD;
  Intraluminal thrombus volume&#xD;
  Calcification volume</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Total Volume measurement of AAA</measure>
      <time_frame>Month 3</time_frame>
      <description>Description of the volume measurement of the AAA with the following items:&#xD;
  Volume circulating&#xD;
  Intraluminal thrombus volume&#xD;
  Calcification volume</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Total Volume measurement of AAA</measure>
      <time_frame>Month 6</time_frame>
      <description>Description of the volume measurement of the AAA with the following items:&#xD;
  Volume circulating&#xD;
  Intraluminal thrombus volume&#xD;
  Calcification volume</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Total Volume measurement of AAA</measure>
      <time_frame>Month 12</time_frame>
      <description>Description of the volume measurement of the AAA with the following items:&#xD;
  Volume circulating&#xD;
  Intraluminal thrombus volume&#xD;
  Calcification volume</description>
    </secondary_outcome>
    <number_of_groups>1</number_of_groups>
    <enrollment type="Actual">0</enrollment>
    <condition>Aneurysm Aortic</condition>
    <arm_group>
      <arm_group_label>Patient with infrarenal abdominal aortic aneurysms</arm_group_label>
      <description>Patient with infrarenal abdominal aortic aneurysms treated with EVAR</description>
    </arm_group>
    <intervention>
      <intervention_type>Procedure</intervention_type>
      <intervention_name>CT-Scan</intervention_name>
      <description>semi-automated analyse by anatomical landmarks with a dedicated fully automated software</description>
      <arm_group_label>Patient with infrarenal abdominal aortic aneurysms</arm_group_label>
    </intervention>
    <eligibility>
      <study_pop>
        <textblock>
          Male or female ≥18 years of age with an Infra-renal Abdominal Aortic Aneurysm treated with&#xD;
          endovascular treatment, ≥50mm, or ≥5mm increase in 6 months or surviving Ruptured AAA&#xD;
        </textblock>
      </study_pop>
      <sampling_method>Non-Probability Sample</sampling_method>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            -  Male or female ≥18 years of age&#xD;
  &#xD;
            -  Infra-renal Abdominal Aortic Aneurysm (AAA) treated with EVAR&#xD;
  &#xD;
                 -  ≥50mm&#xD;
  &#xD;
                 -  or ≥5mm increase in 6 months&#xD;
  &#xD;
                 -  or surviving Ruptured AAA&#xD;
  &#xD;
            -  legal capacity to make own decisions, informed of the nature of the registry, has&#xD;
               signed non opposition form available for set-up and proper implementation of follow-up&#xD;
               visits throughout the duration of the registry&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            -  Advancing Alzheimer's disease or socially dependent patient&#xD;
  &#xD;
            -  Opposition to the use of their data for this research&#xD;
  &#xD;
            -  Life expectancy supposed to be inferior to 2 years Pregnant female&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>18 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
    </eligibility>
    <overall_official>
      <last_name>Eric Ducasse, MD, PhD</last_name>
      <role>Principal Investigator</role>
      <affiliation>University Hospital, Bordeaux</affiliation>
    </overall_official>
    <location>
      <facility>
        <name>Service de Chirurgie Vasculaire, Hôpital Pellegrin-tripode, CHU de Bordeaux</name>
        <address>
          <city>Bordeaux cedex</city>
          <zip>33076</zip>
          <country>France</country>
        </address>
      </facility>
    </location>
    <location_countries>
      <country>France</country>
    </location_countries>
    <verification_date>July 2023</verification_date>
    <study_first_submitted>May 11, 2023</study_first_submitted>
    <study_first_submitted_qc>July 19, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">July 27, 2023</study_first_posted>
    <last_update_submitted>July 19, 2023</last_update_submitted>
    <last_update_submitted_qc>July 19, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">July 27, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Sponsor</responsible_party_type>
    </responsible_party>
    <keyword>Abdominal Aortic Aneurysm</keyword>
    <keyword>CT scan</keyword>
    <keyword>Semi-automated analyses</keyword>
    <keyword>Software</keyword>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Aneurysm</mesh_term>
      <mesh_term>Aortic Aneurysm</mesh_term>
    </condition_browse>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05964348
  org study id: CHUBX 2022/66
  nct id: NCT05964348
  lead sponsor: 
  collaborator: 
  has dmc: No
  is fda regulated drug: No
  is fda regulated device: No
  The objective of this registry is to find and validate a correlation between morphological
        indicators such as volume sac evolution, graft migration or length between anatomical
        landmarks with aneurysm rupture risk or complications such as endoleaks requiring
        re-intervention… Secondary objectives are the validation of the reproducibility and accuracy
        of a dedicated fully automated software enabling Abdominal Aortic Aneurysm (AAA) segmentation
        to measure AAA diameter, volume evolution and growth over time, proximal and distal sealing
        zones analyze as well as device migration and integrity after EVAR on computed tomography
        angiography (CTA). This validation is in comparison with semi-automated analyse controlled by
        physician.
  observational model: Cohort
  time perspective: Retrospective
  measure: Collection of the different events and complications of the aneurysm post EVAR
  time frame: Month 1
  description: Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study
  measure: Collection of the different events and complications of the aneurysm post EVAR
  time frame: Month 3
  description: Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study
  measure: Collection of the different events and complications of the aneurysm post EVAR
  time frame: Month 6
  description: Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study
  measure: Collection of the different events and complications of the aneurysm post EVAR
  time frame: Month 12
  description: Collection of the different events and complication occurred after the EVAR (post-operative (up to one month), 3, 6 and 12 months). The collection will be use to correlate with the measurement of the morphological indicators collected at the different time frame of the study
  measure: Measurement of aneurysm sac volume evolution
  time frame: Month 1
  description: Measurement of the aneurysm sac volume in cc on the CT scans available
  measure: Measurement of aneurysm sac volume evolution
  time frame: Month 3
  description: Measurement of the aneurysm sac volume in cc on the CT scans available
  measure: Measurement of aneurysm sac volume evolution
  time frame: Month 6
  description: Measurement of the aneurysm sac volume in cc on the CT scans available
  measure: Measurement of aneurysm sac volume evolution
  time frame: Month 12
  description: Measurement of the aneurysm sac volume in cc on the CT scans available
  measure: Measurement of morphological neck characteristics
  time frame: Month 6 before intervention
  description: Measurement of the morphological neck characteristics in mm on the CT scans available
  measure: Measurement of morphological neck characteristics
  time frame: Month 1
  description: Measurement of the morphological neck characteristics in mm on the CT scans available
  measure: Measurement of morphological neck characteristics
  time frame: Month 3
  description: Measurement of the morphological neck characteristics in mm on the CT scans available
  measure: Measurement of morphological neck characteristics
  time frame: Month 6
  description: Measurement of the morphological neck characteristics in mm on the CT scans available
  measure: Measurement of morphological neck characteristics
  time frame: Month 12
  description: Measurement of the morphological neck characteristics in mm on the CT scans available
  measure: Measurement of graft migration
  time frame: 6 months before intervention
  description: Measurement of the graft migration if existing on the CT scans available
  measure: Measurement of graft migration
  time frame: Month 1
  description: Measurement of the graft migration if existing on the CT scans available
  measure: Measurement of graft migration
  time frame: Month 3
  description: Measurement of the graft migration if existing on the CT scans available
  measure: Measurement of graft migration
  time frame: Month 6
  description: Measurement of the graft migration if existing on the CT scans available
  measure: Measurement of graft migration
  time frame: Month 12
  description: Measurement of the graft migration if existing on the CT scans available
  measure: Measurement of length between anatomical points evolution
  time frame: 6 months before intervention
  description: Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.
  measure: Measurement of length between anatomical points evolution
  time frame: Month 1
  description: Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.
  measure: Measurement of length between anatomical points evolution
  time frame: Month 3
  description: Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.
  measure: Measurement of length between anatomical points evolution
  time frame: Month 6
  description: Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.
  measure: Measurement of length between anatomical points evolution
  time frame: Month 12
  description: Measurement of the length between anatomical points evolution of the aneurysm in mm on the CT scans available.
  measure: Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation
  time frame: Month
  description: Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis
  measure: Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation
  time frame: 6 months before intervention
  description: Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis
  measure: Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation
  time frame: Month 1
  description: Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis
  measure: Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation
  time frame: Month 3
  description: Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis
  measure: Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation
  time frame: Month 6
  description: Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis
  measure: Repeatability between one senior and one junior surgeon (inter observer variability) for the Semi-automatic segmentation
  time frame: Month 12
  description: Descriptive analysis of the semi-automatic segmentation for the junior and senior surgeon by overlaps metric analysis
  measure: Repeatability between measures (intra observer variability)
  time frame: 6 months before intervention
  description: Descriptive analysis of the different measurements by overlaps metric analysis
  measure: Repeatability between measures (intra observer variability)
  time frame: Month 1
  description: Descriptive analysis of the different measurements by overlaps metric analysis
  measure: Repeatability between measures (intra observer variability)
  time frame: Month 3
  description: Descriptive analysis of the different measurements by overlaps metric analysis
  measure: Repeatability between measures (intra observer variability)
  time frame: Month 6
  description: Descriptive analysis of the different measurements by overlaps metric analysis
  measure: Repeatability between measures (intra observer variability)
  time frame: Month 12
  description: Descriptive analysis of the different measurements by overlaps metric analysis
  measure: Average time for segmentation (sec)
  time frame: 6 months before intervention
  description: The time for segmentation by junior/senior surgeon and software is recorded
  measure: Average time for segmentation (sec)
  time frame: Month 1
  description: The time for segmentation by junior/senior surgeon and software is recorded
  measure: Average time for segmentation (sec)
  time frame: Month 3
  description: The time for segmentation by junior/senior surgeon and software is recorded
  measure: Average time for segmentation (sec)
  time frame: Month 6
  description: The time for segmentation by junior/senior surgeon and software is recorded
  measure: Average time for segmentation (sec)
  time frame: Month 12
  description: The time for segmentation by junior/senior surgeon and software is recorded
  measure: Average time for segmentation in comparison with semi-automated segmentation
  time frame: 6 months before intervention
  description: Description of the average time between the different techniques.
  measure: Average time for segmentation in comparison with semi-automated segmentation
  time frame: Month 1
  description: Description of the average time between the different techniques.
  measure: Average time for segmentation in comparison with semi-automated segmentation
  time frame: Month 3
  description: Description of the average time between the different techniques.
  measure: Average time for segmentation in comparison with semi-automated segmentation
  time frame: Month 6
  description: Description of the average time between the different techniques.
  measure: Average time for segmentation in comparison with semi-automated segmentation
  time frame: Month 12
  description: Description of the average time between the different techniques.
  measure: Total Volume measurement of AAA
  time frame: 6 months before intervention
  description: Description of the volume measurement of the AAA with the following items:
  Volume circulating
  Intraluminal thrombus volume
  Calcification volume
  measure: Total Volume measurement of AAA
  time frame: Month 1
  description: Description of the volume measurement of the AAA with the following items:
  Volume circulating
  Intraluminal thrombus volume
  Calcification volume
  measure: Total Volume measurement of AAA
  time frame: Month 3
  description: Description of the volume measurement of the AAA with the following items:
  Volume circulating
  Intraluminal thrombus volume
  Calcification volume
  measure: Total Volume measurement of AAA
  time frame: Month 6
  description: Description of the volume measurement of the AAA with the following items:
  Volume circulating
  Intraluminal thrombus volume
  Calcification volume
  measure: Total Volume measurement of AAA
  time frame: Month 12
  description: Description of the volume measurement of the AAA with the following items:
  Volume circulating
  Intraluminal thrombus volume
  Calcification volume
  arm group label: Patient with infrarenal abdominal aortic aneurysms
  description: Patient with infrarenal abdominal aortic aneurysms treated with EVAR
  intervention type: Procedure
  intervention name: CT-Scan
  description: semi-automated analyse by anatomical landmarks with a dedicated fully automated software
  arm group label: Patient with infrarenal abdominal aortic aneurysms
  study pop: 
  sampling method: Non-Probability Sample
  criteria: 
  gender: All
  minimum age: 18 Years
  maximum age: N/A
  last name: Eric Ducasse, MD, PhD
  role: Principal Investigator
  affiliation: University Hospital, Bordeaux
  facility: 
  country: France
  responsible party type: Sponsor
  mesh term: Aneurysm
  mesh term: Aortic Aneurysm